Literature DB >> 6831771

Early pregnancy factor is an immunosuppressive contaminant of commercial preparations of human chorionic gonadotrophin.

B E Rolfe, H Morton, F M Clarke.   

Abstract

Early pregnancy factor (EPF) is a pregnancy associated substance detected in human serum and urine throughout the first and second trimesters of pregnancy. It has also been detected in several commercial preparations of human chorionic gonadotrophin (hCG). The various molecular weight forms of EPF which occur in human pregnancy serum, urine and commercial hCG preparations have been partially characterized and found to be similar to each other but distinct from hCG. Further evidence is presented which suggests that it is EPF rather than hCG which is responsible for the immunosuppressive activity of some crude hCG preparations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831771      PMCID: PMC1536762     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  The effects of crude and purified human gonadotropin on in vitro stimulated human lymphocyte cultures.

Authors:  J H Morse; G Stearns; J Arden; G M Agosto; R E Canfield
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

2.  Soluble factors in tolerance and contact sensitivity to DNFB in mice. II. Genetic requirements for suppression of contact sensitivity by soluble suppressor factor.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

3.  Immunological reactivity during pregnancy in the mouse.

Authors:  N Fabris
Journal:  Experientia       Date:  1973-05-15

4.  Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy.

Authors:  D T Purtilo; H M Hallgren; E J Yunis
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

5.  A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone.

Authors:  J L Vaitukaitis; G D Braunstein; G T Ross
Journal:  Am J Obstet Gynecol       Date:  1972-07-15       Impact factor: 8.661

6.  Effect of human chorionic gonadotropin on in vitro lymphocyte transformation.

Authors:  M D Kaye; W R Jones
Journal:  Am J Obstet Gynecol       Date:  1971-04-01       Impact factor: 8.661

7.  Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression.

Authors:  E W Adcock; T Teasdale; C S August; S Cox; G Meschia; T C Ballaglia; M A Naughton
Journal:  Science       Date:  1973-08-31       Impact factor: 47.728

8.  An early pregnancy factor detected in human serum by the rosette inhibition test.

Authors:  H Morton; B Rolfe; G J Clunie
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

Review 9.  Changes in plasma proteins during pregnancy.

Authors:  J C Joseph; C Baker; M L Sprang; E W Bermes
Journal:  Ann Clin Lab Sci       Date:  1978 Mar-Apr       Impact factor: 1.256

10.  Immunoregulatory properties of fractions from human pregnancy urine: evidence that human chorionic gonadotropin is not responsible.

Authors:  A V Muchmore; R M Blaese
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

View more
  3 in total

1.  Identification of two suppressor factors induced by early pregnancy factor.

Authors:  B E Rolfe; A C Cavanagh; K A Quinn; H Morton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

2.  Human early pregnancy factor: serum concentrations before and after therapeutic abortion in comparison with beta-hCG and an early pregnancy associated protein.

Authors:  W Straube; V Hübel; M Loh; S Leipe
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Type I collagen synthesis by human osteoblasts in response to placental lactogen and chaperonin 10, a homolog of early-pregnancy factor.

Authors:  J P Mansell; S J Yarram; N L Brown; J R Sandy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-10       Impact factor: 2.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.